探索喘的潜在治疗点:一个全蛋白质组的门德尔随机化分析
Yuhan Jiang1,2, Yifan Wang1,2, Ju Guo3
1Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China.
Journal of translational medicine
|October 30, 2024
概括
这项研究确定了75种与喘风险相关的血蛋白,其中6种被验证为潜在的治疗点. 马克斯蛋白具有很高的药用性,为喘药物开发提供了新的途径.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是全球主要的健康问题,患病率和死亡率很高.
- 目前的治疗方法对于许多严重的喘病例是不够的,需要新的治疗策略.
- 识别与喘风险相关的循环血蛋白对于开发新疗法至关重要.
研究的目的:
- 使用孟德尔随机化研究循环等离子体蛋白与喘风险之间的关联.
- 通过分析蛋白质关联和药物可用性来确定喘的潜在药物点.
- 为了探索血蛋白与喘亚型的联系,用于向治疗.
主要方法:
- 在英国生物库数据上使用基于总结数据的门德尔随机化 (MR) 和两样 MR.
- 利用发现 (FinnGen) 和复制 (GERA) 队列与贝叶斯协同定位进行验证.
- 进行了蛋白质-蛋白质相互作用,药物可用性和候选药物的预测分析.
主要成果:
- 在发现队列中确定了与喘相关的75种血蛋白,包括IL1RAP,IL1RL1,IL6,CXCL5和CXCL8.
- 通过同定位和复制验证了6种蛋白质 (IL4R,LTB,CASP8,MAX,PCDH12,SCLY).
- MAX蛋白显示出显著的可药性潜力;IL4R,CASP8和SCLY被确定为潜在的药物标.
结论:
- 建立了血蛋白和喘之间的联系,增强了对其分子病原学的理解.
- 发现了喘的新型潜在治疗点,包括MAX,IL4R,CASP8和SCLY.
- 这些发现为喘药物向研究和开发提供了新的见解.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Asthma: Pathogenesis and Management
361
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
361
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234


